Literature DB >> 26173940

Rash and multiorgan dysfunction following lamotrigine: could genetic be involved?

Alessio Provenzani1, Manuela Labbozzetta2, Monica Notarbartolo2, Paola Poma2, Piera Polidori3, Giovanni Vizzini4, Natale D'Alessandro2.   

Abstract

CASE (DESCRIPTION): We report the case of a 38-year-old woman treated with lamotrigine who experienced multi-organ dysfunction. The patient received the drug at the dose of 100 mg per day. One week later, the treatment was suspended because of an extensive body rash. Twenty-four hours later, the patient appeared drowsy and stuporous and was hospitalized. On the fifth day, the patient was admitted with a clinical picture of acute multi-organ failure in our Institute, where, she, despite the support of vital functions with vasoactive drugs, continuous hemofiltration and ventilation with oxygen, died. Serum lamotrigine concentration was measured 110 h after its last dose and the drug resulted to be still present at 1 mg/L. The patient was homozygous for the UGT1A4-70C and UGT2B7-161C alleles and heterozygous for the UGT2B7-372A>G polymorphism. Regarding ABCB1 the patient showed the 3435CC, 2677GT and 1236CT genotypes.
CONCLUSION: Our results may suggest a role of the UGT2B7-372A>G polymorphism in this reaction.

Entities:  

Keywords:  ABCB1; Antiepileptic drugs; HLA; Lamotrigine; Multi-organ dysfunction; Pharmacogenetics; Rash; SNPs; UGT1A4; UGT2B7

Mesh:

Substances:

Year:  2015        PMID: 26173940     DOI: 10.1007/s11096-015-0158-4

Source DB:  PubMed          Journal:  Int J Clin Pharm


  36 in total

1.  Successful treatment of severe lamotrigine and clonazepam poisoning by blood purification.

Authors:  Jianrao Lu; Chongxiang Xiong; Xinghua Wang; Jing Hu; Xiufeng Chen
Journal:  Blood Purif       Date:  2012-06-20       Impact factor: 2.614

2.  Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients.

Authors:  M Holthe; T N Rakvåg; P Klepstad; J R Idle; S Kaasa; H E Krokan; F Skorpen
Journal:  Pharmacogenomics J       Date:  2003       Impact factor: 3.550

Review 3.  Pathogenesis and clinical approaches to anticonvulsant hypersensitivity syndrome: current state of knowledge.

Authors:  A Scaparrotta; A Verrotti; N P Consilvio; A Cingolani; S Di Pillo; M Di Gioacchino; M Verini; F Chiarelli
Journal:  Int J Immunopathol Pharmacol       Date:  2011 Apr-Jun       Impact factor: 3.219

4.  Association between lamotrigine concentrations and ABCB1 polymorphisms in patients with epilepsy.

Authors:  Mila Lovrić; Nada Božina; Sanja Hajnšek; Martina Rojnić Kuzman; Davor Sporiš; Zdenka Lalić; Tamara Božina; Paula Granić
Journal:  Ther Drug Monit       Date:  2012-10       Impact factor: 3.681

Review 5.  [Therapeutic drug monitoring of lamotrigine].

Authors:  Danièle Bentué-Ferrer; Olivier Tribut; Marie-Clémence Verdier
Journal:  Therapie       Date:  2010-03-08       Impact factor: 2.070

6.  Functional analysis of UGT1A4(P24T) and UGT1A4(L48V) variant enzymes.

Authors:  Jin Zhou; Upendra A Argikar; Rory P Remmel
Journal:  Pharmacogenomics       Date:  2011-11-02       Impact factor: 2.533

Review 7.  Pharmacogenetics of drug transporters.

Authors:  R M Franke; E R Gardner; A Sparreboom
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

8.  Functional evaluation of polymorphisms in the human ABCB1 gene and the impact on clinical responses of antiepileptic drugs.

Authors:  Chin-Chuan Hung; Chih-Chuan Chen; Chun-Jung Lin; Horng-Huei Liou
Journal:  Pharmacogenet Genomics       Date:  2008-05       Impact factor: 2.089

9.  Influence of the UGT2B7 -161C>T polymorphism on the population pharmacokinetics of lamotrigine in Thai patients.

Authors:  Noppaket Singkham; Somchai Towanabut; Surang Lertkachatarn; Baralee Punyawudho
Journal:  Eur J Clin Pharmacol       Date:  2012-12-21       Impact factor: 2.953

10.  A multi-system approach assessing the interaction of anticonvulsants with P-gp.

Authors:  David Dickens; Siti R Yusof; N Joan Abbott; Babette Weksler; Ignacio A Romero; Pierre-Olivier Couraud; Ana Alfirevic; Munir Pirmohamed; Andrew Owen
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.